Invesco EBIT

The latest EBIT for IVZ is $-630M as of June 2026. That compares with $950M in the prior-year period — down 165.8% year over year. That is below the Finance sector average of $340B. Investors often review this figure alongside Invesco's historical trend and sector peers before judging valuation or financial health.

Over the past year, IVZ's EBIT moved from $950M to $-630M — a 165.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Invesco's operating scale or balance-sheet position.

Against Finance companies, IVZ currently prints $-630M for EBIT, while the sector average sits near $340B. That is roughly 100.2% below the sector mean. Large gaps often invite a closer look at Invesco's growth, margins, and balance sheet.

A EBIT figure of $-630M for IVZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Finance average is about $340B. Explore the charts below for those layers of context.

After noting IVZ's EBIT ($-630M), review year-over-year change from $950M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.